A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Sensex
74,151.04
▲ +1.24%
Nifty
22,936.75
▲ +1.05%
22k Gold
₹ 13,195/gm
Silver
₹ 2,15,000/kg
Petrol
₹ 111.21
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 110.64
USD
₹ 95.26
Sensex
74,151.04
▲ +1.24%
Nifty
22,936.75
▲ +1.05%
22k Gold
₹ 13,195/gm
Silver
₹ 2,15,000/kg
Petrol
₹ 111.21
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 110.64
USD
₹ 95.26
SBI Healthcare Opportunities Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
91.59% ↑
NAV (₹) on 28 Oct 2026
580.18
1 Day NAV Change
1.10%
Risk Level
Very High Risk
Rating
-
SBI Healthcare Opportunities Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by SBI Funds Management Ltd.. Launched on 01 Jan 2013, investors can start with a minimum SIP ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
01 Jan 2013
Min. Lumpsum Amount
₹ 5,000
Fund Age
13 Yrs
AUM
₹ 5,870 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
1.01%
Scheme Type
Open Ended
Exit Load
0.50%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 5,870 Cr
Equity
95.52%
Debt
0.05%
Money Market & Cash
6.42%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 67.01% |
| Hospitals & Medical Services | 24.52% |
| Treps/Reverse Repo | 6.42% |
| Chemicals - Speciality | 2.17% |
| Medical Equipment & Accessories | 1.82% |
| Treasury Bill | 0.05% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.14% | ₹ 653.98 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 7.91% | ₹ 464.57 | Pharmaceuticals |
| TREPS | 6.42% | ₹ 377.01 | Others |
| Acutaas Chemicals Ltd. | 5.03% | ₹ 295.15 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 4.45% | ₹ 261.30 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 4.42% | ₹ 259.20 | Pharmaceuticals |
| Cipla Ltd. | 4.40% | ₹ 258.43 | Pharmaceuticals |
| Laurus Labs Ltd. | 4.05% | ₹ 237.60 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 3.80% | ₹ 223.15 | Hospitals & Medical Services |
| Aurobindo Pharma Ltd. | 3.42% | ₹ 200.64 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 3.21% | ₹ 188.23 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 2.96% | ₹ 173.96 | Pharmaceuticals |
| Sudeep Pharma Ltd. | 2.79% | ₹ 163.99 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 2.75% | ₹ 161.42 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 2.60% | ₹ 152.45 | Pharmaceuticals |
| Corona Remedies Ltd. | 2.43% | ₹ 142.35 | Pharmaceuticals |
| Biocon Ltd. | 2.37% | ₹ 138.86 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.36% | ₹ 138.60 | Hospitals & Medical Services |
| Concord Biotech Ltd. | 2.25% | ₹ 131.87 | Pharmaceuticals |
| Aether Industries Ltd. | 2.17% | ₹ 127.45 | Chemicals - Speciality |
| Jupiter Life Line Hospitals Ltd. | 2.16% | ₹ 126.80 | Hospitals & Medical Services |
| Polymedicure Ltd. | 1.82% | ₹ 107.12 | Medical Equipment & Accessories |
| Ajanta Pharma Ltd. | 1.79% | ₹ 104.93 | Pharmaceuticals |
| Global Health Ltd. | 1.74% | ₹ 102.38 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 1.71% | ₹ 100.15 | Pharmaceuticals |
| Healthcare Global Enterprises Ltd. | 1.70% | ₹ 99.91 | Hospitals & Medical Services |
| Krishna Institute of Medical Sciences Ltd. | 1.69% | ₹ 99.36 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 1.66% | ₹ 97.68 | Pharmaceuticals |
| Innova Captab Ltd. | 1.65% | ₹ 96.64 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 1.62% | ₹ 95.38 | Hospitals & Medical Services |
| Nephrocare Health Service Pvt. Ltd. | 1.12% | ₹ 65.97 | Hospitals & Medical Services |
| Syngene International Ltd. | 1.12% | ₹ 65.75 | Pharmaceuticals |
| Rainbow Children's Medicare Ltd. | 0.67% | ₹ 39.43 | Hospitals & Medical Services |
| Gufic Biosciences Ltd. | 0.29% | ₹ 17.28 | Pharmaceuticals |
| Abbott India Ltd. | 0.23% | ₹ 13.56 | Pharmaceuticals |
| 364 DAY T-BILL 19.11.26 | 0.05% | ₹ 2.98 | Others |
| Novartis India Ltd. | 0.04% | ₹ 2.34 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 24.46% | 15.87% | 10.86% | 24.20% |
| Category returns | 2.73% | -1.24% | 3.27% | 20.44% |
Fund Objective
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes ... Read more
AMC Details
Name
SBI Funds Management Ltd.
Date of Incorporation
29 Jun 1987
CEO
Mr. Nand Kishore
CIO
Mr. Rajeev Radhakrishnan, Mr. Rama Iyer Srinivasan
Type
Bank Sponsored
Address
9th Floor, Crescenzo,
C-38 & 39, G Block,
Bandra-Kurla Complex,
Bandra (East), Mumbai, Maharashtra, India - 400051
Website
https://www.sbimf.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.77 | 92.86% | 308.35% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.77 | 92.86% | 308.35% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.77 | 92.86% | 308.35% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.41 | 90.31% | 291.89% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.41 | 90.31% | 291.89% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.41 | 90.31% | 291.89% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.09 | 14.92% | 146.75% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.09 | 14.92% | 146.75% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.09 | 14.92% | 146.75% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.02 | 13.82% | 138.94% | 0.00% | ₹11,493 | 1.79% |
Very High
|
Top Funds from SBI Funds Management Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹43.16 | 21.29% | 127.13% | 183.46% | ₹17,423 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹43.16 | 21.29% | 127.13% | 183.46% | ₹17,423 | 0.25% |
Very High
|
|
SBI Gold Fund - Direct Plan
Fund of Funds
Direct
|
₹43.23 | 21.29% | 127.13% | 183.46% | ₹17,423 | 0.25% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹41.21 | 21.09% | 125.85% | 180.13% | ₹17,423 | 0.42% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹41.22 | 21.08% | 125.83% | 180.10% | ₹17,423 | 0.42% |
Very High
|
|
SBI Gold Fund
Fund of Funds
Regular
|
₹41.22 | 21.08% | 125.83% | 180.10% | ₹17,423 | 0.42% |
Very High
|
|
SBI Gold ETF
ETF
Regular
|
₹120.69 | 19.86% | 125.13% | 182.76% | ₹26,466 | 0.65% |
High
|
|
SBI US Specific Equity Active FoF - Direct Plan
Fund of Funds
Direct
|
₹25.11 | 17.10% | 117.13% | 110.55% | ₹1,168 | 1.03% |
Very High
|
|
SBI US Specific Equity Active FoF - Direct Plan
Fund of Funds
Direct
|
₹25.11 | 17.10% | 117.12% | 110.54% | ₹1,168 | 1.03% |
Very High
|
|
SBI US Specific Equity Active FoF - Direct Plan
Fund of Funds
Direct
|
₹25.11 | 17.10% | 117.12% | 110.54% | ₹1,168 | 1.03% |
Very High
|
FAQs
What is the current NAV of SBI Healthcare Opportunities Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹580.18 as of 28 Oct 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth?
The Assets Under Management (AUM) of SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹5,870.00 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of SBI Healthcare Opportunities Fund - Direct Plan Growth?
SBI Healthcare Opportunities Fund - Direct Plan Growth has delivered returns of 15.87% (1 Year), 24.20% (3 Year), 19.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of SBI Healthcare Opportunities Fund - Direct Plan Growth?
SBI Healthcare Opportunities Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for SBI Healthcare Opportunities Fund - Direct Plan Growth?
The minimum lumpsum investment required for SBI Healthcare Opportunities Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+
X